Oral thrush in adults treatment
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Here is a comprehensive summary of oral thrush treatment in adults, drawn from multiple authoritative textbooks:
Oral Thrush (Oral Candidiasis) in Adults — Treatment
Overview
Oral thrush is caused predominantly by Candida albicans. In adults, predisposing factors include antibiotic use, diabetes, dry mouth, dentures, inhaled corticosteroids, and immunosuppression (HIV/AIDS, chemotherapy, transplant). Finding thrush in an adult with no obvious predisposing factor warrants evaluation for HIV.
Treatment by Severity
Mild Disease — Topical Agents (First-Line)
| Agent | Dose/Regimen |
|---|---|
| Clotrimazole troches (10 mg) | Dissolve in mouth 5× daily for 1–2 weeks |
| Miconazole buccal tablets (50 mg) | Once daily for 1–2 weeks |
| Nystatin suspension (100,000 units/mL) | 4–6 mL swish-and-swallow, 4× daily for 1–2 weeks |
- Clotrimazole troches are described as a "pleasant-tasting alternative to nystatin."
- Denture disinfection is also important in denture wearers.
Moderate–Severe Disease or Immunosuppressed Patients — Systemic Azoles (First-Line)
| Agent | Dose |
|---|---|
| Fluconazole (oral) | 100–200 mg/day for 1–2 weeks; a single 150 mg dose may suffice for many mucocutaneous infections |
| Itraconazole | Effective alternative |
Refractory or Azole-Resistant Disease — Second-Line Options
- Posaconazole
- Voriconazole
- Amphotericin B suspension/solution
- Echinocandins (for chronic mucocutaneous candidiasis)
Special Considerations
- Esophageal involvement: Systemic azole therapy (fluconazole) is mandatory — topical agents are insufficient.
- HIV/AIDS patients: Higher doses of fluconazole may be required; azole resistance can develop with prolonged use.
- Chronic mucocutaneous candidiasis: Long courses of oral imidazoles or triazoles (voriconazole, posaconazole) are often needed; resistant cases may require echinocandins or liposomal amphotericin B.
- Inhaled corticosteroid users: Rinsing the mouth after each inhalation reduces risk.
Summary Table (IDSA-aligned)
| Severity | First-Line | Second-Line |
|---|---|---|
| Mild | Clotrimazole troches or miconazole buccal tablet | Nystatin suspension |
| Moderate/Severe | Oral fluconazole 100–200 mg/day × 1–2 weeks | Itraconazole, posaconazole, voriconazole, or AmB solution |
| Immunosuppressed/Refractory | Fluconazole at higher doses | Echinocandins, liposomal AmB |
Sources: Harrison's Principles of Internal Medicine 22E, p. 1225 | Andrews' Diseases of the Skin, p. 354 | Fitzpatrick's Dermatology, p. 2987
This is a shared conversation. Sign in to Orris to start your own chat.